IN THIS ISSUE/RESEARCH WATCH/NEWS-IN-BRIEF/NEWS FROM THE IASLC TOBACCO CONTROL COMMITTEE
Glasgow Prognostic Score: Another Global Positioning System to Assess Patients with Lung Cancer?
Chasing Therapeutic Targets in Thymic Malignancies: Finding Needles in the Haystack to Frame a Comprehensive Canvas?
Staging, Tumor Profile, and Prognostic Groups in Lung Cancer or the New Tower of Babel
The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer
A Primer on Health Economic Evaluations in Thoracic Oncology
Is the Canonical RAF/MEK/ERK Signaling Pathway a Therapeutic Target in SCLC?
Acquired Resistance to Crizotinib in NSCLC with MET Exon 14 Skipping
Consensus Report of the 2015 Weinman International Conference on Mesothelioma
Effect of First-Line Treatment on Myeloid-Derived Suppressor Cells' Subpopulations in the Peripheral Blood of Patients with Non–Small Cell Lung Cancer
An Activating KIT Mutation Induces Crizotinib Resistance in ROS1-Positive Lung Cancer
Deep Sequencing Analysis Reveals That KRAS Mutation Is a Marker of Poor Prognosis in Patients with Pulmonary Sarcomatoid Carcinoma
Identifying the Appropriate FISH Criteria for Defining MET Copy Number–Driven Lung Adenocarcinoma through Oncogene Overlap Analysis
Current Patterns of Care for Patients with Extensive-Stage SCLC: Survey of U.S. Radiation Oncologists on Their Recommendations Regarding Prophylactic Cranial Irradiation
Value of the Glasgow Prognostic Score as a Prognostic Factor in Resectable Non–Small Cell Lung Cancer
Pretreatment Anemia Portends Poor Survival and Nonlocal Disease Progression in Patients with Stage I Non–Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy
Thoracoscopic Lobectomy Produces Long-Term Survival Similar to That with Open Lobectomy in Cases of Non–Small Cell Lung Carcinoma: A Propensity-Matched Analysis Using a Population-Based Cancer Registry
North American Multicenter Volumetric CT Study for Clinical Staging of Malignant Pleural Mesothelioma: Feasibility and Logistics of Setting Up a Quantitative Imaging Study
PI3K as a Potential Therapeutic Target in Thymic Epithelial Tumors
Axl Receptor Axis: A New Therapeutic Target in Lung Cancer
Practical Assessment of Bronchoscopically Inserted Fiducial Markers for Image Guidance in Stereotactic Lung Radiotherapy
Plasma T790M Result Alters Treatment Options in a Previously T790 Wild-Type EGFR -Mutant Lung Cancer
Pitfalls in Oncology: Osteoblastic Response Mimicking Bone Progression during Ceritinib Treatment in ALK -Rearranged NSCLC
On the Article “Nodal Upstaging Is More Common with Thoracotomy Than with VATS during Lobectomy for Early-Stage Lung Cancer: An Analysis from the National Cancer Data Base” by Medbery et al.
Location, Location, Location: The Reality of Tumor Real Estate and Nodal Upstaging